Last reviewed · How we verify
NCT06177262
Characteristics of Illness Awareness in Anorexia Nervosa
trial testing cognitive behavioral therapy in Insight Impaired in 80 participants. Status unknown.
1 August 2024
Quick facts
| Lead sponsor | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 80 |
| Start date | 1 December 2022 |
| Primary completion | 1 August 2024 |
| Estimated completion | 1 December 2024 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- cognitive behavioral therapy
Conditions studied
- Insight Impaired — all drugs for Insight Impaired →
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Who can join
Adults 18 to 65, female only, with Insight Impaired. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Objective: To study the characteristics of illness awareness, its dimensions and its evolution in relation to clinical, cognitive and psychosocial variables in patients with anorexia nervosa. Design: observational longitudinal design. Method: First, the process of translating and culturally adapting the Schedule for the Assessment of Insight in Eating Disorders (SAI-ED) to Spanish will be carried out and, over 9 months, patients who are admitted to the Eating Disorders Unit of the Hospital de la Santa Creu I Sant Pau (HSCSP) and the Eating Disorders Unit of the H. Mutua de Terrassa will be offered to participate in the study. Through individual clinical interviews and self-reports, a first sample will be collected to allow the validation study of the scale in the Spanish population. The sample will include patients with Anorexia Nervosa and Bulimia Nervosa who understand and speak Spanish or Catalan and sign the informed consent for participation. Participants will be recruited consecutively until N=80 is reached. From a subsample of patients with anorexia nervosa, data related to illness awareness and other clinical, cognitive and psychosocial variables will be collected longitudinally in the 3 and 6 months after. Finally, a quantitative analysis of the results obtained will be carried out.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Understanding the structure of insight in eating disorders: validation of the SAI-ED in a Spanish clinical sample.
Gawron LP, Garrido-Ribas I, Carmona-Farrés C, Carril-Batuecas S, et al · · 2025 · cited 1× · PMID 40855569 · DOI 10.1186/s40337-025-01360-5
Verify or expand the search:
- PubMed search for NCT06177262
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of cognitive behavioral therapy
Trials testing the same drug.
- NCT07281352 — RCT of Psilocybin-assisted CBT for Depression · Phase 1, PHASE2 · recruiting
- NCT06208111 — A Clinical Trial of Cognitive Behavior Therapy for Depression, Stigmatization, Excessive Worries, and Emotional Manageme · NA · unknown
- NCT06064032 — Cognitive Behavioral Therapy And Motor Learning Technique Among Attention Deficit Hyperactivity Disorder Adults · NA · unknown
- NCT06013085 — Effects of Cognitive-behavioral Therapy for Insomnia in Nurses With Post Covid-19 Condition · NA · not yet recruiting
- NCT05593796 — Cognitive Behavioral Therapy(CBT) in Treatment of Methamphetamine Use Disorder · NA · unknown
Other Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau trials
Trials by the same sponsor.
- NCT07343882 — Quantification of Systemic Congestion by Ultrasound As a Predictor of Weaning Failure From Mechanical Ventilation · NA · not yet recruiting
- NCT07530237 — Efficacy of Periarticular Vasoconstrictor Infiltration (PVI) in Reducing Bleeding and Postoperative Pain in Lumbar Fusio · active not recruiting
- NCT07369310 — Comparing Biomarker-Guided DBS Programming With Standard Clinical Monopolar Programming · NA · not yet recruiting
- NCT07314190 — Retrospective Observational Study of Blood-based Biomarkers in the Diagnosis and Monitoring of Patients With a Neurodege · enrolling by invitation
- NCT07239843 — Prospective Observational Study of the Relationship Between Sociodemographic Factors, Blood-based Biomarkers and Psychia · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06177262 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Last refreshed: 20 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06177262.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing